Lymphoma,Other Cancers BRUIN MCL-321 Trial: Pirtobrutinib vs. Investigator-Selected BTK Inhibitor in MCL Jun 30, 2023
Lymphoma,Other Cancers Brentuximab Vedotin's Stage III or IV Hodgkin's Lymphoma Survival Jun 23, 2023
Lymphoma,Other Cancers Enhancing Hodgkin Lymphoma Treatment: Pembrolizumab with Chemotherapy in Newly Diagnosed Patients Jun 08, 2023
Lymphoma,Other Cancers Improved Treatment for High-Risk Pediatric Hodgkin's Lymphoma: Brentuximab Vedotin and Chemotherapy Jun 08, 2023
FL (Follicular Lymphoma),Lymphoma Bone Marrow Biopsies in NCI-NCTN Follicular Lymphoma Trials: Response Relevance Evaluated Jun 01, 2023
DLBCL (Diffuse Large B Cell Lymphoma),Lymphoma REMoDL-B Phase 3 Study: Evaluation of Molecular Guided Therapy for DLBCL Apr 20, 2023
